ARS Pharmaceuticals Inc. (SPRY)
NASDAQ: SPRY
· Real-Time Price · USD
14.53
0.06 (0.41%)
At close: Aug 15, 2025, 3:59 PM
14.65
0.83%
After-hours: Aug 15, 2025, 07:32 PM EDT
ARS Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -48.02M | -15.65M | 8M | -49.1M | -44.84M | -49.7M | -54.37M | -61.63M | -53.34M | -42.39M | -34.68M | -43.71M | -59.78M | -77.86M | -89.48M | -72.48M | -55.11M | -30.61M |
Depreciation & Amortization | -2.9M | -3.16M | -1.47M | 62K | 62K | 64K | 73K | 360K | 346K | 289K | 319K | 450K | 984K | 1.51M | 1.93M | 1.9M | 1.76M | 1.27M |
Stock-Based Compensation | 18.52M | 16.52M | 14.53M | 12.55M | 11.57M | 10.3M | 9.23M | 11.72M | 9.57M | 7.83M | 5.84M | 1.24M | 1.69M | 2.22M | 2.83M | 2.67M | 1.75M | 877.5K |
Other Working Capital | -20.54M | -19.85M | -13.95M | -6.3M | -396K | -977K | -4.55M | -15.2M | -8.26M | -5.95M | -3.25M | 6.24M | -2.26M | -4.13M | -4.43M | -1.96M | -427K | -984K |
Other Non-Cash Items | 6.68M | 5.14M | 3.16M | 12.59M | 3.98M | 4.13M | 4.3M | -4.19M | -2.59M | -755K | 1.05M | 6.52M | 12.95M | 14M | 17.01M | 10.74M | 4.34M | 3.21M |
Deferred Income Tax | n/a | n/a | n/a | -11.18M | -11.18M | -11.18M | -11.18M | 143K | 143K | 143K | 143K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -27.09M | -23.33M | -10.68M | -10.77M | -3.74M | -7.17M | -7.33M | -8.77M | -9.4M | -10.7M | -12.75M | -3.98M | -6.4M | -302K | 1.6M | 5.52M | 4.72M | -415K |
Operating Cash Flow | -52.8M | -20.48M | 13.55M | -45.86M | -44.16M | -53.55M | -59.27M | -62.36M | -55.28M | -45.58M | -40.08M | -40.89M | -54.32M | -61.48M | -66.76M | -50.9M | -39.41M | -25.27M |
Capital Expenditures | -584K | -571K | -563K | -170K | -73K | -65K | -175K | -392K | -379K | -371K | -199K | -623K | -680K | -1.36M | -1.37M | -827K | -773K | -73K |
Cash Acquisitions | n/a | n/a | n/a | -25.95M | 20.65M | 20.65M | 132M | 157.95M | 111.35M | 111.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -270.72M | -326.95M | -356.04M | -226.63M | -291.69M | -204.08M | -272M | -237.95M | -131.35M | -131.35M | n/a | -25.14M | -65.11M | -65.11M | -65.11M | -39.97M | n/a | n/a |
Sales Maturities Of Investments | 271.5M | 266.5M | 258M | 251M | 250M | 220M | 185M | 125M | 65M | 20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -7.5M | -7.5M | -7.5M | 23.45M | -20.65M | 24.35M | -87M | -112.95M | -66.35M | -111.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -7.31M | -68.52M | -106.1M | 21.7M | -41.76M | 15.85M | -87.18M | -113.34M | -66.73M | -111.72M | -199K | -25.76M | -65.79M | -66.46M | -66.48M | -40.8M | -773K | -73K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.95M | -6.86M | -7.77M | -8.68M | -2.73M | -1.82M | -1.4M | -846K | -963K | -1.31M | -817K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 72.08M | 69.38M | 69.38M | n/a | n/a | 2.85M | 4.17M | 203.95M | 203.3M | 200.73M | 199.41M | -360K | 435K | 148K | 370K | 370K | 222K | 222K |
Financial Cash Flow | 75.02M | 72.87M | 72.4M | 3.29M | 3.53M | 5.84M | 6.9M | 198.91M | 196.44M | 192.96M | 190.73M | -2.81M | -1.11M | -166K | 614K | 12.27M | 33.44M | 33.12M |
Net Cash Flow | 14.91M | -16.14M | -20.15M | -20.88M | -82.39M | -31.86M | -139.55M | 23.21M | 74.43M | 35.65M | 150.46M | -69.36M | -121.12M | -128.01M | -132.52M | -85.91M | -26.88M | -12.36M |
Free Cash Flow | -53.38M | -21.05M | 12.98M | -46.03M | -44.23M | -53.61M | -59.44M | -62.75M | -55.66M | -45.95M | -40.28M | -41.51M | -55M | -62.84M | -68.13M | -51.73M | -40.18M | -25.34M |